title: Colchicine--what is its place in the management of acute gout?
abstract: This series of articles facilitated by the Cochrane Musculoskeletal Group (CMSG) aims to place the findings of recent Cochrane musculoskeletal reviews in a context immediately relevant to general practitioners. This article considers the place of colchicine in the management of acute gout.
authors.affiliation: Menzies Research Institute, University of Tasmania. tania.winzenberg@utas.edu.au
authors.forename: Tania
authors.initials: T
authors.lastname: Winzenberg
authors.forename: Jane
authors.initials: J
authors.lastname: Zochling
mesh_terms: D000368:Aged; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000627:therapeutic use; D001315:Australia / Q000453:epidemiology; D003078:Colchicine / Q000009:adverse effects / Q000627:therapeutic use*; D005194:Family Practice / Q000706:statistics & numerical data; D006073:Gout / Q000188:drug therapy* / Q000453:epidemiology / Q000503:physiopathology; D006074:Gout Suppressants / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D006074:Gout Suppressants; D003078:Colchicine